Prof.Dr. Neslihan Cabıoğlu

Member

Neslihan Çabıoğlu is a professional with experience in patient communication, organization, and awareness-raising in the healthcare field. She applies the knowledge gained from her civil society projects to education and support activities aimed at increasing breast health awareness. She actively participates in projects, events, and awareness-raising activities carried out within the Breast Health Association (MEMEDER), contributing to the association's mission of strengthening its social impact.

Secondary Education:
Istanbul Erkek High School, 1988 (Graduation)

Medical Education:
Istanbul Faculty of Medicine, 1994 (Graduation)

General Surgery Residency:
Department of General Surgery, Istanbul Faculty of Medicine (1994–2000)

PhD in Immunology:
Institute of Experimental Medical Research, Department of Immunology (1998–2001)

Postdoctoral Fellowship:
MD Anderson Cancer Center; Department of Surgical Oncology and Cancer Biology and Breast Pathology (2001–2005).

Ministry of Health Haseki Training and Research Hospital, 2005–2007.

Istanbul University, Istanbul Faculty of Medicine, Department of General Surgery (2007–2008)

Ministry of Health Haseki Training and Research Hospital (2008–2011)

Associate Professorship in General Surgery:
January 2009.

Acıbadem University Faculty of Medicine, Department of General Surgery and Breast Health Center (February 2011–November 2013):
Served as 4th-Year General Surgery Education Coordinator and Assistant Coordinator of 4th-Year Surgical Sciences (2012–2013).

Istanbul University, Istanbul Faculty of Medicine; Department of General Surgery; November 2013–Present

International Appointments:
Royal Liverpool University, Department of Immunology, Liverpool, United Kingdom, July–August 1992, Immunology Summer Internship.

Ludwig Maximilian University of Munich (Grosshadern), Department of Obstetrics and Gynecology, Munich, Germany, July–August 1993, 5-week Summer Internship.

South Manchester University Hospital Breast Clinic, Manchester, United Kingdom, September 2001, one-month observation and practice with the “AstraZeneca Breast Cancer Clinical Fellowship.”

Departments of Surgical Oncology and Cancer Biology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA; October 2001–January 2004.

Department of Breast Pathology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA; February 2004–January 2005.

The University of Pittsburgh – Department of Surgery and Combined Breast Program of UPMC/Magee-Womens Hospital, May 2–May 6, 2011.

European Academy of Senology Certificate, June 2014
(February 2014 and June 2014, Düsseldorf; Luisen Hospital; under the supervision of Prof. Dr. Mahdi Rezai)

IBUS Breast Ultrasonography Certificate (June 2014; Istanbul).

SELECTED PUBLICATIONS:
1. N. Cabioglu, Kuerer, H.M. “Nipple discharge and ductal secretions,” Advanced Therapy of Breast Diseases, third edition, eds. G.V. Babiera, R.J. Skoracki, F.J. Esteva, pp. 311–337, People’s Medical Publishing House, Shelton, Connecticut, USA, 2012.

2. Yazici H, Bitisik O, Akisik E, N. Cabioglu, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis I, Dalay N, Ozcelik H. “BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients,” Br J Cancer 2000; 83: 737–742.

3. Cabioglu N., A. Igci, E. Aktas, E.O. Yildirim, S. Bilgic, M. Muslumanoglu, Y. Bozfakioglu, M. Kecer, V. Ozmen, G. Deniz. “An ultrasensitive tumor-enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer,” Am J Surg 2002; 184: 414–417.

4. Cabioglu N., K.K. Hunt, S.E. Singletary, T.W. Stephens, S. Marcy, F. Meric, M.I. Ross, G.V. Babiera, F.C. Ames, H.M. Kuerer. “Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge,” J Am Coll Surg 2003; 196: 354–364.

5. Cabioglu N., S. Krishnamurthy, H.M. Kuerer, K.K. Hunt, S.E. Singletary, F. Meric-Bernstam, M.I. Ross, B.W. Feig, F.C. Ames, G.V. Babiera. “Feasibility of breast-conserving surgery in patients with breast cancer associated with nipple discharge,” Cancer 2004; 101: 508–517.

6. Cabioglu N., K.K. Hunt, T.A. Buchholz, N. Mirza, S.E. Singletary, H.M. Kuerer, G.V. Babiera, F.C. Ames, A.A. Sahin, F. Meric-Bernstam. “Improving local control with breast-conserving therapy: a 27-year single-institution experience,” Cancer 2005; 104: 20–29.

7. Cabioglu N., J. Summy, C. Miller, N. Parikh, A. Sahin, S. Tuzlali, K. Pumiglia, G.E. Gallick, J.E. Price. “CXCL-12/stromal cell-derived factor-1 alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation,” Cancer Research 2005; 65: 6493–6497.

8. Cabioglu N., M.S. Yazici, B. Arun, K.R. Broglio, G.N. Hortobagyi, J.E. Price, A.A. Sahin. “CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer,” Clinical Cancer Research 2005; 11: 5686–5693.

9. Cabioglu N., A. Sahin, M. Doucet, E. Yavuz, A. Igci, E.O. Yildirim, E. Aktas, S. Bilgic, B. Kiran, G. Deniz, J.E. Price. “Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow,” Clinical & Experimental Metastasis 2005; 22: 39–46.

10. Andre F., N. Cabioglu, H. Assi, J.C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, C. Combadiere, C. Bucana, J.C. Soria, M. Cristofanilli. “Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node-positive primary breast cancer,” Annals of Oncology 2006; 17: 945–951.